Back to search results
NCT07279311

Virtual Reality-enhanced Psychotherapy for Perinatal Depression

Enrolling by Invitation
NAAges 18+InterventionalTreatment
Stanford University
~44 participants
Updated 2026-04-06 on ClinicalTrials.gov
What's tested:Virtual reality behavioral activation

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Depressive symptoms scale score using Edinburgh Postnatal Depression Scale (EPDS)
Measured over At enrollment, then weekly up to a total of 3 weeks

Conditions

Depression During Pregnancy

Explore related trials

Depression

NCT07279311

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Lucile Packard Children's Hospital

    Palo Alto, Californiano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Danielle M Panelli, MD MS · PRINCIPAL_INVESTIGATOR · Stanford University

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients admitted to Stanford Children's Hospital antepartum unit for obstetric indications that are likely to warrant \>3 weeks of hospitalization (such as vasa previa, preterm premature rupture of membranes, severe preeclampsia).
Able to read and write in English or Spanish
Baseline EPDS score on admission \>=10 on routine screening
Admitted \>24 hours prior to enrollment

Exclusion

Patients with serious neuropsychiatric illness (bipolar disorder, schizophrenia, epilepsy, or suicidal ideation)
Known delivery planned within the next 3 weeks

What this trial measures

  • Depressive symptoms scale score using Edinburgh Postnatal Depression Scale (EPDS)At enrollment, then weekly up to a total of 3 weeks

    Edinburgh Postnatal Depression Scale (EPDS) scores will be compared at the end of the 3 week intervention between groups. The EPDS is a 10-item questionnaire, with total score 0-30. Higher scores are consistent with greater levels of depressive symptoms.